| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy
|
Wiersinga, Wilmar M
|
|
2017
|
5 |
2 |
p. 134-142
9 p.
|
article
|
| 2 |
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial
|
Thabit, Hood
|
|
2017
|
5 |
2 |
p. 117-124
8 p.
|
article
|
| 3 |
Closer to closing the loop on inpatient glycaemia
|
Rayman, Gerry
|
|
2017
|
5 |
2 |
p. 81-83
3 p.
|
article
|
| 4 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 943–56
|
|
|
2017
|
5 |
2 |
p. e1-
1 p.
|
article
|
| 5 |
Correction to Lancet Diabetes Endocrinol 2017: 5: 125–33
|
|
|
2017
|
5 |
2 |
p. e1-
1 p.
|
article
|
| 6 |
De-evolution of diagnostic testing for adrenal insufficiency
|
Kline, Gregory A
|
|
2017
|
5 |
2 |
p. 88-90
3 p.
|
article
|
| 7 |
Diabetic macular oedema
|
Tan, Gavin S
|
|
2017
|
5 |
2 |
p. 143-155
13 p.
|
article
|
| 8 |
Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial
|
Pasquel, Francisco J
|
|
2017
|
5 |
2 |
p. 125-133
9 p.
|
article
|
| 9 |
Foods, nutrients, and health: when will our policies catch up with nutrition science?
|
Mozaffarian, Dariush
|
|
2017
|
5 |
2 |
p. 85-88
4 p.
|
article
|
| 10 |
Giant gouty tophi in the hands
|
Han, Bing
|
|
2017
|
5 |
2 |
p. 156-
1 p.
|
article
|
| 11 |
Growing a billion dollar industry
|
Mitchell, Fiona
|
|
2017
|
5 |
2 |
p. 96-
1 p.
|
article
|
| 12 |
How concerned should we be over the long-term safety of growth hormone therapy?
|
Tritos, Nicholas A
|
|
2017
|
5 |
2 |
p. 79-81
3 p.
|
article
|
| 13 |
Inpatient care and diabetes: putting poor glycaemic control to bed
|
The Lancet Diabetes & Endocrinology,
|
|
2017
|
5 |
2 |
p. 77-
1 p.
|
article
|
| 14 |
Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool
|
Geldsetzer, Pascal
|
|
2017
|
5 |
2 |
p. 91-92
2 p.
|
article
|
| 15 |
Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study
|
van der Steen, Manouk
|
|
2017
|
5 |
2 |
p. 106-116
11 p.
|
article
|
| 16 |
Non-communicable disease funding
|
Allen, Luke
|
|
2017
|
5 |
2 |
p. 92-
1 p.
|
article
|
| 17 |
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
|
Schmidt, Amand F
|
|
2017
|
5 |
2 |
p. 97-105
9 p.
|
article
|
| 18 |
PCSK9 inhibition and diabetes: turning to Mendel for clues
|
Lee, Jooho
|
|
2017
|
5 |
2 |
p. 78-79
2 p.
|
article
|
| 19 |
Prediabetes definitions and clinical outcomes
|
Huang, Yuli
|
|
2017
|
5 |
2 |
p. 93-
1 p.
|
article
|
| 20 |
Prediabetes definitions and clinical outcomes
|
Lima, Luís Maurício T R
|
|
2017
|
5 |
2 |
p. 92-93
2 p.
|
article
|
| 21 |
Prediabetes definitions and clinical outcomes – Authors' reply
|
Selvin, Elizabeth
|
|
2017
|
5 |
2 |
p. 94-
1 p.
|
article
|
| 22 |
Research in brief
|
Kang, Seema
|
|
2017
|
5 |
2 |
p. 95-
1 p.
|
article
|
| 23 |
Sitagliptin plus basal insulin: simplifying in-hospital diabetes treatment?
|
Nauck, Michael A
|
|
2017
|
5 |
2 |
p. 83-85
3 p.
|
article
|
Journal description